United States
US 12,697,346 B2
Thiarabine- and thiarabine prodrug-based treatments
US 12,697,346 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-04. Applicant: Southern Research Institute. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- Southern Research Institute
- Inventors
- Omar Moukha-Chafiq; Mark J. Suto; Jie Liu; Rebecca Boohaker; Corinne E. Augelli-Szafran
- Publication date
- 2026-08-04
- Filing date
- 2021-11-12
- Document type
- B2 Granted patent
- Also written as
- US 12,697,346 B2 · US12697346 · 12697346
Abstract
The present disclosure is concerned with combination therapies that include sulfur-based nucleotide and nucleoside compounds for the treatment of various cancers such as, for example, sarcomas, carcinomas, hematological cancers, solid tumors, breast cancer, cervical cancer, gastrointestinal cancer, colorectal cancer, brain cancer, skin cancer, prostate cancer, ovarian cancer, bladder cancer, thyroid cancer, testicular cancer, pancreatic cancer, endometrial cancer, melanomas, gliomas, leukemias, lymphomas, chronic myeloproliferative disorders, myelodysplastic syndromes, myeloproliferative neopl…
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free